Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1548 of 5804
-
New antibody takes aim at Hard-to-Treat cancers
Disease control OngoingThis is a multicenter, Phase II, open-label, single-dose-level (6 mg/kg) study of PRL3-zumab monotherapy in patients with unresectable or metastatic solid tumors. PRL3-zumab will be administered via intravenous (IV) infusion until discontinuation criteria are met (e.g., disease p…
Phase: PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New biosimilar aims to tame stubborn hives at lower cost
Disease control CompletedThe purpose of the study is to compare the efficacy, pharmacokinetics, pharmacodynamics, safety, tolerability, and immunogenicity of TEV-45779 compared to XOLAIR in patients with Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) who remain symptomatic on H1 antihistamine treatm…
Phase: PHASE3 • Sponsor: Teva Pharmaceuticals USA • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill cuts hot flashes in half for menopausal women
Symptom relief CompletedResearchers are looking for a better way to treat women who have hot flashes after women have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual…
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could a common diabetes drug help fight TB in HIV patients?
Disease control CompletedThe METHOD study will examine whether adding metformin to standard antibiotic treatment for tuberculosis (TB) in people with HIV is safe and well tolerated. The study will also test if adding metformin clears the infection more quickly and with less lung damage. When enrolled, pa…
Phase: PHASE2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a Baby's cord blood predict leukemia years later?
Knowledge-focused Recruiting nowA comprehensive mechanistic and epidemiological study to obtain banked cord blood samples from consecutive childhood leukemia patients enrolled in the COG Project:EveryChild (APEC14B1) study. Will attempt to backtrack the initiating genomic alteration identified in the matched di…
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Gene test may spare melanoma patients unnecessary surgery
Diagnosis OngoingMERLIN\_001 is a prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and to determine its prognostic value for more accurate staging of SN-negative melanoma patients.
Sponsor: SkylineDx • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New eye drops show promise for healing corneal damage
Disease control CompletedThis study will enroll subjects with stage 2 or 3 neurotrophic keratitis. Subjects will be randomized in a 1:1 ratio to the CSB-001 investigational treatment arm or vehicle control arm. All subjects will dose with the randomized treatment four times daily for 8 weeks (controlled …
Phase: PHASE1, PHASE2 • Sponsor: Claris Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for HS patients: Long-Term drug shows promise
Disease control CompletedThis study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants who completed treatment can join this study. The purpose of this study is to find out how safe spesolimab is and whether it helps p…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can medical cannabis help chronic pain patients taper off opioids?
Symptom relief CompletedThis study will use a randomized controlled design to test whether medical marijuana use by adults on high-dose chronic opioid therapy (COT) for chronic non-cancer pain is associated with reduced opioid dose and improved pain intensity and interference when added to a 24-week beh…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can cutting calories boost Radiation's power against breast cancer?
Disease control Recruiting nowThis phase II trial studies the effect of calorie reduction while undergoing stereotactic ablative radiation therapy in treating patients with breast cancer. Stereotactic ablative radiation therapy (sABR) is a highly focused radiation treatment that gives an intense dose of radia…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Helmet-Style brain stimulation may beat standard treatment for resistant depression
Symptom relief Recruiting nowThe main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil. The patient will receive treatment arm A or B : Arm A : classic rTMS treatment (use of the 8-shaped coil) and standard therapy Arm B: treatment with deep rTMS (us…
Phase: NA • Sponsor: Centre Hospitalier Henri Laborit • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy shows promise for rare bleeding disorder
Disease control OngoingThe project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytope…
Phase: PHASE2 • Sponsor: Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study aims : * To assess the efficacy of fluorometholone 0.1% one drop twice daily for four weeks in reducing the incidence of post-operative trachomatous trichiasis (TT) when given as adjunctive therapy with TT surgery in the programmatic setting * To assess whether such t…
Phase: PHASE3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo tackles Drug-Resistant melanoma
Disease control OngoingThis phase I/II trial investigates the best dose, possible benefits and/or side effects of tazemetostat in combination with dabrafenib and trametinib in treating patients with melanoma that has a specific mutation in the BRAF gene (BRAFV600) and that has spread from where it firs…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Custom-Made vaccine takes on untreated leukemia in early trial
Disease control Recruiting nowThis research study is studying a novel type of CLL vaccine as a possible treatment for chronic lymphocytic leukemia (CLL) The names of the study interventions involved in this study are: * Personalized NeoAntigen Vaccine * Poly-ICLC * Cyclophosphamide * Pembrolizumab
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Simple test could cut unnecessary hospital visits for chest pain
Diagnosis CompletedThe goal of this clustered, diagnostic randomized controlled trial is to study a clinical decision rule including a high-sensitive troponin I point of care test in patients with chest pain in primary care. The main questions it aims to answer are: 1. Can unnecessary referrals t…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Diagnosis
Last updated Jun 26, 2026 16:20 UTC
-
New drug shows promise against fatty liver and scarring
Disease control CompletedSaroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Rapid HIV tests could end the epidemic by diagnosing in minutes
Diagnosis CompletedThis study proposes to investigate the performance of existing and new technologies for HIV diagnosis, one of the key strategies for Ending the HIV Epidemic in the U.S. Current, Standard-of-Care (SOC) diagnostic techniques have extended turn-around-times (TATs) that result in los…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could skin cells heal stubborn leg wounds? new trial tests a One-Time treatment
Disease control CompletedThe aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction of CVUs) and safety (by monitoring adverse events \[AEs\]) of three dose groups of the investigational medicinal product (IMP) allo-APZ2-CVU, topically administered on target wou…
Phase: PHASE2 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo shows promise for Tough-to-Treat liver cancer
Disease control CompletedThis phase II trial studies the effect of futibatinib and pembrolizumab in treating patients with FGF19 positive BCLC stage A, B, or C liver cancer that has spread to other parts of the body (advanced or metastatic). Futibatinib may stop the growth of cancer cells by blocking som…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC